CHELSEA THERAPEUTICS INTERNATIO CHTP (NASDAQ)

$ 1.92
11/18/2008 24:00
Sponsored by
Click here!
Change: unch (unch%)
Volume: 15,480

Avg. Volume: 36774
P/E Ratio: 0
EPS (Annual): -0.85
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 29,990
Institutional Shareholders: 46.38%
Last: 1.92
Change: unch (unch%)
Prev. Close: 1.92
Open: 2.09
Day's Range: 1.92 - 2.09
52wk Range: 1.50 - 8.41
Market Value: 59,180
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: -69.13%
Total Return Last 3 Years: -18.97%
Total Return Last 5 Years: -68.00%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on CHTP

Chelsea Therapeutics' loss widens in 2nd quarter

(CHARLOTTE, N.C.)Drug developer Chelsea Therapeutics International said Wednesday its loss widened in the second quarter as it increased spending on research and development.READ MORE
Aug 06, 2008 3:50PM
Keywords: CHTP
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN INC. +9.80 56.34
GILEAD SCIENCES -3.90 45.22
CELGENE CORPORA -10.10 57.57
STEMCELLS INC. -61.50 1.13
BIOGEN IDEC INC -30.40 43.80